Tag: data quality

Aligning RBM KPIs With Corporate Quality and Operational Objectives Aligning RBM KPIs With Corporate Quality and Operational Objectives Risk-Based Monitoring (RBM) has transformed the landscape of clinical trials, particularly in the context of maintaining compliance with regulatory standards set by authorities such as the FDA, EMA, and MHRA. In this comprehensive guide, we will focus…

Read More “Aligning RBM KPIs With Corporate Quality and Operational Objectives” »

Case Studies: RBM Programs That Demonstrated Clear ROI Case Studies: RBM Programs That Demonstrated Clear ROI In the rapidly evolving landscape of clinical trials, organizations are increasingly adopting risk-based monitoring (RBM) strategies to enhance efficiency and ensure compliance with regulatory standards. This article provides a comprehensive guide through case studies that illustrate the return on…

Read More “Case Studies: RBM Programs That Demonstrated Clear ROI” »

Collecting Qualitative Feedback From Sites, CRAs and Study Teams on RBM In the evolving landscape of clinical trials, effective risk-based monitoring (RBM) has emerged as a cornerstone strategy to optimize site performance, enhance data integrity, and ensure patient safety. One essential aspect often overlooked is the collection of qualitative feedback from various stakeholders such as…

Read More “Collecting Qualitative Feedback From Sites, CRAs and Study Teams on RBM” »

Regulatory Interest in RBM Outcomes: How to Frame Metrics and Results Regulatory Interest in RBM Outcomes: How to Frame Metrics and Results In the realm of clinical trials, the efficacy and efficiency underpinned by Risk-Based Monitoring (RBM) have garnered significant regulatory interest. This comprehensive tutorial aims to equip clinical operations, regulatory affairs, and medical affairs…

Read More “Regulatory Interest in RBM Outcomes: How to Frame Metrics and Results” »

Using Metrics to Refine RACT, CtQ, KRIs and QTLs Over Time Using Metrics to Refine RACT, CtQ, KRIs and QTLs Over Time In the realm of pharmaceutical clinical trials, the effective management and evaluation of risk are paramount to ensure compliance with regulatory requirements and the overall success of the study. Key performance metrics such…

Read More “Using Metrics to Refine RACT, CtQ, KRIs and QTLs Over Time” »

RBM Maturity Models and Benchmarking Against Industry Peers RBM Maturity Models and Benchmarking Against Industry Peers As clinical trials evolve, the need for effective risk-based monitoring (RBM) strategies has become paramount. The goal of RBM is to focus resources on the most significant risks associated with clinical trials, ensuring that data integrity and patient safety…

Read More “RBM Maturity Models and Benchmarking Against Industry Peers” »

Comparing Pre- and Post-RBM Performance Across Trials and Portfolios Comparing Pre- and Post-RBM Performance Across Trials and Portfolios Introduction to Risk-Based Monitoring (RBM) The landscape of clinical trials is undergoing a transformation with the adoption of Risk-Based Monitoring (RBM) methodologies. Traditional monitoring methods often lead to inefficiencies, resource wastage, and increased timelines, which can impede…

Read More “Comparing Pre- and Post-RBM Performance Across Trials and Portfolios” »

<!– Metadata Dashboards for RBM Effectiveness: What to Track Monthly and Quarterly –> Dashboards for RBM Effectiveness: What to Track Monthly and Quarterly In the realm of clinical trials, particularly for covid clinical trials, the adoption of Risk-Based Monitoring (RBM) is essential in ensuring that trial operations operate efficiently while maintaining compliance with regulatory standards….

Read More “Dashboards for RBM Effectiveness: What to Track Monthly and Quarterly” »

Defining Success Criteria for Risk-Based Monitoring Implementations Defining Success Criteria for Risk-Based Monitoring Implementations Introduction to Risk-Based Monitoring in Clinical Trials Risk-Based Monitoring (RBM) has emerged as a key strategy in the management of clinical trials, particularly in ensuring quality and compliance throughout the study lifecycle. This approach allows for the identification and mitigation of…

Read More “Defining Success Criteria for Risk-Based Monitoring Implementations” »

Linking RBM Metrics to Fewer Deviations, Faster Database Lock and Lower Cost Risk-Based Monitoring (RBM) has emerged as a pivotal approach in the conduct of pharma clinical trials, offering a more efficient, quality-driven methodology that mitigates risk while ensuring regulatory compliance. This tutorial guide outlines a systematic approach for clinical operations, regulatory affairs, and medical…

Read More “Linking RBM Metrics to Fewer Deviations, Faster Database Lock and Lower Cost” »